They were deliberately selected for OGM validation to resent a variety of BCR::ABL1 positive cases (CML vs. ALL, p210 vs. p190 BCR::ABL1 transcripts; cryptic variants, etc.). Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.